The markets have reacted positively to the news that NZ-listed Pumpkin Patch is to dump 20 of is badly performing US stores.
The children’s clothing label has decided to close 20 of the 35 stores in the US as the stores continued to under perform and were causing problems with the company’s bottom line.
Pumpkin Patch’s share price was up 9.6% at 11.53 today after a busy morning trade. The shareprice now sits at $1.48 – still considerably below the 52-week high of $1.64.
It is not surprising that the reaction to the news has been so good as there have been calls for Pumpkin Patch to rid itself of some of its US interests for sometime as these operation had been affected its bottom line.
Pumpkin Patch’s US operations recorded a net profit loss of $8.9 million even though retail sales were up 50.6% to $27.3 million for the half year ended January 31.
Had the US operations ebit not been included in the group’s results for this period, its ebit would have been up 9.5% rather than down 7%.
The news that the company has also managed to reduce debt by 60% and now forecasted that its year end bank debt would be lower than the predicted $30-40m. Good news in a market where there is a high degree of uncertainly to how long the current economic downturn will last.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Marlborough-based wine company lists on the NXT despite OIO hiccup
- New lawyers not doing 'much better' than job at McDonald's – report surprises
- Sky TV-Vodafone merger application highlights threats – including those to key sports content
- NZSA unsure on merits of Nuplex takeover
- Business confidence perks up in June as construction, tourism underpin economy
Most listened to
- Marlborough Wine Estates CEO Catherine Ma explains why the Chinese-owned company listed on the NXT
- National list MP Chris Bishop says Phil Twyford's accusation the government has made housing a 'race issue' is hypocritical
- NBR technology editor Chris Keall on hitting 4000 member subscribers
- In his Editor's Insight Nevil Gibson on the future of health information technology and medical devices industry
- Transferring client funds to buy a car and not declaring conflicts of interest; NBR's Hamish McNicol on the accounting indiscretion